Kristiansen G - Search Results

1

Quantitative determination of estrogen receptor, progesterone receptor, and HER2 mRNA in formalin-fixed paraffin-embedded tissue--a new option for predictive biomarker assessment in breast cancer.

Müller BM, Kronenwett R, Hennig G, Euting H, Weber K, Bohmann K, Weichert W, Altmann G, Roth C, Winzer KJ, Kristiansen G, Petry C, Dietel M, Denkert C. Müller BM, et al. Among authors: kristiansen g. Diagn Mol Pathol. 2011 Mar;20(1):1-10. doi: 10.1097/PDM.0b013e3181e3630c. Diagn Mol Pathol. 2011. PMID: 21326033

2

Overexpression of c-erbB2 protein correlates with disease-stage and chromosomal gain at the c-erbB2 locus in non-small cell lung cancer.

Kristiansen G, Yu Y, Petersen S, Kaufmann O, Schlüns K, Dietel M, Petersen I. Kristiansen G, et al. Eur J Cancer. 2001 Jun;37(9):1089-95. doi: 10.1016/s0959-8049(01)00096-x. Eur J Cancer. 2001. PMID: 11378338

3

CD10 expression in non-small cell lung cancer.

Kristiansen G, Schlüns K, Yongwei Y, Dietel M, Petersen I. Kristiansen G, et al. Anal Cell Pathol. 2002;24(1):41-6. doi: 10.1155/2002/781580. Anal Cell Pathol. 2002. PMID: 12122282 Free PMC article.

4

CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival.

Kristiansen G, Denkert C, Schlüns K, Dahl E, Pilarsky C, Hauptmann S. Kristiansen G, et al. Am J Pathol. 2002 Oct;161(4):1215-21. doi: 10.1016/S0002-9440(10)64398-2. Am J Pathol. 2002. PMID: 12368195 Free PMC article.

5

ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions.

Kristiansen G, Pilarsky C, Wissmann C, Stephan C, Weissbach L, Loy V, Loening S, Dietel M, Rosenthal A. Kristiansen G, et al. Prostate. 2003 Jan 1;54(1):34-43. doi: 10.1002/pros.10161. Prostate. 2003. PMID: 12481253

6

CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients.

Kristiansen G, Schlüns K, Yongwei Y, Denkert C, Dietel M, Petersen I. Kristiansen G, et al. Br J Cancer. 2003 Jan 27;88(2):231-6. doi: 10.1038/sj.bjc.6600702. Br J Cancer. 2003. PMID: 12610508 Free PMC article.

7

Expression of the cell adhesion molecule CD146/MCAM in non-small cell lung cancer.

Kristiansen G, Yu Y, Schlüns K, Sers C, Dietel M, Petersen I. Kristiansen G, et al. Anal Cell Pathol. 2003;25(2):77-81. doi: 10.1155/2003/574829. Anal Cell Pathol. 2003. PMID: 12632016 Free PMC article.

8

Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma.

Denkert C, Winzer KJ, Müller BM, Weichert W, Pest S, Köbel M, Kristiansen G, Reles A, Siegert A, Guski H, Hauptmann S. Denkert C, et al. Among authors: kristiansen g. Cancer. 2003 Jun 15;97(12):2978-87. doi: 10.1002/cncr.11437. Cancer. 2003. PMID: 12784332 Free article.

9

CD24 expression is a new prognostic marker in breast cancer.

Kristiansen G, Winzer KJ, Mayordomo E, Bellach J, Schlüns K, Denkert C, Dahl E, Pilarsky C, Altevogt P, Guski H, Dietel M. Kristiansen G, et al. Clin Cancer Res. 2003 Oct 15;9(13):4906-13. Clin Cancer Res. 2003. PMID: 14581365

10

CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer.

Kristiansen G, Pilarsky C, Pervan J, Stürzebecher B, Stephan C, Jung K, Loening S, Rosenthal A, Dietel M. Kristiansen G, et al. Prostate. 2004 Feb 1;58(2):183-92. doi: 10.1002/pros.10324. Prostate. 2004. PMID: 14716744

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

620 results

Search Page